A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Axatilimab Monotherapy in Japanese Participants With Recurrent or Refractory Active Chronic Graft-Versus-Host Disease
Clinical trial NCT06263478 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06263478
- Sponsor
- Incyte Biosciences Japan GK
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-30
- Primary completion
- 2025-08-06
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.